Molecular Partners Ag (MOLN) Invested Capital (2021 - 2025)
Historic Invested Capital for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to $119418.4.
- Molecular Partners Ag's Invested Capital fell 2544.67% to $119418.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $119418.4, marking a year-over-year decrease of 2544.67%. This contributed to the annual value of $160997.9 for FY2024, which is 1905.51% down from last year.
- Molecular Partners Ag's Invested Capital amounted to $119418.4 in Q3 2025, which was down 2544.67% from $128836.0 recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Invested Capital ranged from a high of $276.1 million in Q2 2022 and a low of $116355.1 during Q4 2021
- In the last 5 years, Molecular Partners Ag's Invested Capital had a median value of $210518.3 in 2023 and averaged $42.5 million.
- In the last 5 years, Molecular Partners Ag's Invested Capital skyrocketed by 10979.51% in 2022 and then crashed by 9992.51% in 2025.
- Quarter analysis of 5 years shows Molecular Partners Ag's Invested Capital stood at $116355.1 in 2021, then skyrocketed by 109.8% to $244107.4 in 2022, then dropped by 18.52% to $198898.0 in 2023, then decreased by 18.71% to $161680.6 in 2024, then dropped by 26.14% to $119418.4 in 2025.
- Its Invested Capital stands at $119418.4 for Q3 2025, versus $128836.0 for Q2 2025 and $142582.7 for Q1 2025.